Quick Answer
TRINITY BIOTECH PLC reported Total Assets of $103.29 million for fiscal year 2024.
TRINITY BIOTECH PLC — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Assets | $103.29M +73.8% |
$59.44M -35.5% |
$92.10M -22.5% |
$118.89M -8.8% |
$130.40M -0.5% |
$131.07M -13.6% |
| R&D Expense | $4.54M +3.7% |
$4.38M +5.8% |
$4.14M -8.0% |
$4.50M -11.5% |
$5.08M -4.6% |
$5.33M -0.8% |
| Gross Profit | $21.44M +10.2% |
$19.45M +12.6% |
$17.27M -48.4% |
$33.45M -31.1% |
$48.58M +27.4% |
$38.12M -8.0% |
- TRINITY BIOTECH PLC reported Total Assets of $103.29 million for fiscal year 2024.
- TRINITY BIOTECH PLC showed an increase of +73.8% in Total Assets compared to the prior fiscal year.
- TRINITY BIOTECH PLC reported R&D Expense of $4.54 million for fiscal year 2024.
- TRINITY BIOTECH PLC showed an increase of +3.7% in R&D Expense compared to the prior fiscal year.
- TRINITY BIOTECH PLC reported Gross Profit of $21.44 million for fiscal year 2024.
- TRINITY BIOTECH PLC showed an increase of +10.2% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: